These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18490333)

  • 1. Myocardial contrast echocardiography in biopsy-proven primary cardiac amyloidosis.
    Abdelmoneim SS; Bernier M; Bellavia D; Syed IS; Mankad SV; Chandrasekaran K; Pellikka PA; Mulvagh SL
    Eur J Echocardiogr; 2008 Mar; 9(2):338-41. PubMed ID: 18490333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: a comparison with coronary angiography and cardiac magnetic resonance.
    Arnold JR; Karamitsos TD; Pegg TJ; Francis JM; Olszewski R; Searle N; Senior R; Neubauer S; Becher H; Selvanayagam JB
    JACC Cardiovasc Imaging; 2010 Sep; 3(9):934-43. PubMed ID: 20846628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac amyloidosis: typical imaging findings and diffuse myocardial damage demonstrated by delayed contrast-enhanced MRI.
    Sueyoshi E; Sakamoto I; Okimoto T; Hayashi K; Tanaka K; Toda G
    Cardiovasc Intervent Radiol; 2006; 29(4):710-2. PubMed ID: 16565801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Doppler imaging and contrast-enhanced cardiac magnetic resonance in primary cardiac amyloidosis.
    Smedema JP; James R
    Eur J Echocardiogr; 2009 Dec; 10(8):984-6. PubMed ID: 19749196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study.
    Senior R; Moreo A; Gaibazzi N; Agati L; Tiemann K; Shivalkar B; von Bardeleben S; Galiuto L; Lardoux H; Trocino G; Carrió I; Le Guludec D; Sambuceti G; Becher H; Colonna P; Ten Cate F; Bramucci E; Cohen A; Bezante G; Aggeli C; Kasprzak JD
    J Am Coll Cardiol; 2013 Oct; 62(15):1353-61. PubMed ID: 23770168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of vasodilator stress myocardial contrast echocardiography and magnetic resonance imaging for the differential diagnosis of ischemic versus nonischemic cardiomyopathy.
    Mor-Avi V; Koch R; Holper EM; Goonewardena S; Coon PD; Min JK; Fedson S; Ward RP; Lang RM
    J Am Soc Echocardiogr; 2008 May; 21(5):425-32. PubMed ID: 18187290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial perfusion imaging with contrast ultrasound.
    Porter TR; Xie F
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):176-87. PubMed ID: 20159645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging in cardiac amyloidosis.
    Pennell DJ; Maceira AM
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1378-80. PubMed ID: 20083071
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
    Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real time myocardial contrast echocardiography during supine bicycle stress and continuous infusion of contrast agent. Cutoff values for myocardial contrast replenishment discriminating abnormal myocardial perfusion.
    Miszalski-Jamka T; Kuntz-Hehner S; Schmidt H; Hammerstingl C; Tiemann K; Ghanem A; Troatz C; Lüderitz B; Omran H
    Echocardiography; 2007 Jul; 24(6):638-48. PubMed ID: 17584204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging.
    Oda S; Utsunomiya D; Nakaura T; Yuki H; Kidoh M; Morita K; Takashio S; Yamamuro M; Izumiya Y; Hirakawa K; Ishida T; Tsujita K; Ueda M; Yamashita T; Ando Y; Hata H; Yamashita Y
    Circ J; 2017 Jun; 81(7):1014-1021. PubMed ID: 28367859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis.
    Roslan A; Kamsani SH; Nay TW; Tan KL; Hakim N; Tan AM; Megat Samsudim WN; Tan KL; Jauhari AT; Krishnan M; Leong D; Supramaniam T; Tan LK; Nuruddin AA
    Med J Malaysia; 2018 Dec; 73(6):388-392. PubMed ID: 30647209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time myocardial contrast echocardiography for pharmacologic stress testing: is quantitative estimation of myocardial blood flow reserve necessary?
    Korosoglou G; da Silva KG; Labadze N; Dubart AE; Hansen A; Rosenberg M; Zehelein J; Kuecherer H
    J Am Soc Echocardiogr; 2004 Jan; 17(1):1-9. PubMed ID: 14712180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial contrast echocardiography in the assessment of patients with chronic coronary artery disease.
    Pérez de Isla L; Serra V; Luis Rodrigo J; Almería C; Aubele A; Luis Zamorano J
    Echocardiography; 2003 Aug; 20 Suppl 1():S31-42. PubMed ID: 23573623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis.
    Bhatti S; Watts E; Syed F; Vallurupalli S; Pandey T; Jambekar K; Mazur W; Hakeem A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):970-7. PubMed ID: 27225804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of cardiac amyloidosis with
    Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy.
    Shimoni S; Frangogiannis NG; Aggeli CJ; Shan K; Verani MS; Quinones MA; Espada R; Letsou GV; Lawrie GM; Winters WL; Reardon MJ; Zoghbi WA
    Circulation; 2003 Feb; 107(4):538-44. PubMed ID: 12566363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.